Head-to-head · WeighScore
Genesis Health vs Nurx
By GLP-1 ScorecardUpdated
Score comparison
Nurx has the higher recorded score — 66.5/100 to 61.4/100.
Nurx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established women's telehealth brand offering tiered GLP-1 weight loss programs.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Genesis Health | Nurx |
|---|---|---|
| WeighScore | 61.4/100 | 66.5/100 |
| Grade | C | C |
| Site position | #331 | #208 |
| Semaglutide | $175/mo (starting dose, compounded) | $179/mo (starting dose, compounded) |
| Tirzepatide | $235/mo (starting dose, compounded) | $179/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #331 · C
FDAWarning letter issued to Genesis Health International Inc. dba Genesis in February 2026. See the FDA warning-letter database.
Strengths
- Annual plan as low as $99/mo for semaglutide or $125/mo for tirzepatide
- Offers both compounded and brand-name GLP-1s (Wegovy, Ozempic, Zepbound) in one platform
- Includes health coaching, active community, and free expedited shipping on every plan
- LegitScript certified; medications sourced from audited, licensed US compounding pharmacies
- Same-day provider visits, personalized dosing, and 24/7 care team messaging
What to consider
- States served not publicly listed; telehealth coverage unconfirmed for all states
- Monthly starting price ($175 sema / $235 tirz) is mid-market without annual commitment
- Labs not disclosed or included in any published plan tier
- Brand-name GLP-1 pricing not published; insurance or coupon required
- FDA issued Genesis Health International Inc. dba Genesis a warning letter in February 2026; the letter is public in FDA's warning-letter database
Site position #208 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
What to consider
- Limited public information on program details
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.